VettaFi Weight Loss Drug & Treatment Index
An index of global companies expected to economically benefit from GLP-1 drug development, approval, or market adoption. This includes companies who are manufacturers in the GLP-1 pharmaceuticals business or are GLP-1 enablers. The index allocates 70% of its weight to a Principal Manufacturers segment and 30% to an Enablers segment.
Quick Links
| As May 17, 2024 | Index Level | 3-Month | 6-Month | 1-Year | YTD |
| Price Return | 1,516.6 | 6.8% | 24.9% | 29.7% | 19.4% |
| Total Return | 1,594.5 | 7.6% | 26.0% | 31.8% | 20.4% |
| Net Total Return | 1,576.1 | 7.4% | 25.7% | 31.3% | 20.2% |
| Index Level | 1,516.6 |
|---|---|
| 3-Month | 6.8% |
| 6-Month | 24.9% |
| 1-Year | 29.7% |
| YTD | 19.4% |
| Index Level | 1,594.5 |
|---|---|
| 3-Month | 7.6% |
| 6-Month | 26.0% |
| 1-Year | 31.8% |
| YTD | 20.4% |
| Index Level | 1,576.1 |
|---|---|
| 3-Month | 7.4% |
| 6-Month | 25.7% |
| 1-Year | 31.3% |
| YTD | 20.2% |
As of May 17, 2024
Characteristics
| Index Symbol (Price Return) | THINR |
| Index Symbol (Total Return) | THINRT |
| Index Symbol (Net Total Return) | THINRN |
| Number of Constituents | 21 |
| Market Capitalization | $2.62 Trillion |
| Adjusted Market Capitalization | $2.42 Trillion |
| Rebalancings | Quarterly |
| Dividend Yield | 1.57% |
Composition
Top Index Constituents
As of May 18, 2024
Interested in Market Data packages?
VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.
Contact Us